# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sigmund Freud (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET005-SYN
- Date: 2026-07-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Anton Reinholt, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Six-week review: cutting down, setting a quit date, pain and weight. **S**

## History of present illness

Mr. Freud returns six weeks after intake. He smokes about six cigars a day and has chosen a quit date one week from today. The quitline has called him three times. The nausea stopped once he took varenicline after food, and the dreams are milder. The relined obturator seals better: liquids leak into his nose only now and then, and his speech is clearer. The sore spot had healed by the two-week check at the prosthodontics clinic. Dr. Vasquez-Lindqvist took impressions for the new obturator last week. The speech-language therapy sessions have not started because the first appointment was cancelled. His pain is 4 of 10 and he is eating more. **S**

| Element | Detail |
|---|---|
| Cigars | About six a day; quit date one week from today |
| Varenicline | 1 mg twice daily after food; no nausea; milder dreams |
| Quitline | Three calls |
| Pain | 4 of 10 |
| Weight | 58.9 kg |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Eating more; no fever |
| Ears, nose, mouth, and throat | Positive | Occasional nasal leakage of liquids; sore spot healed; no bleeding or lump |
| Respiratory | Positive | Morning cough, less than before |
| Psychiatric | Negative | Mood steady; some irritability on low-cigar days |

4 systems reviewed. **S**

## Current medications

- Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeks **S**
- Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy site **S**

## Allergies

- No known allergy **S**

## Objective

BP 134/80 mmHg; pulse 76 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 96% on room air; weight 58.9 kg; BMI 19.9 kg/m². All vital signs are synthetic.

Pain score (0 to 10): 4. All results are synthetic.

## Change since baseline

- Pain score (0 to 10): 6 at baseline, 4 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 134/80, pulse 76; weight 58.9 kg |
| Mouth | With the obturator out: ulcer at the defect margin healed; no mass, induration or white or red patch |
| Neck | No lymph nodes felt |
| Speech | Mild hypernasality with the relined obturator |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Tobacco use disorder, severe, on varenicline** (F17.290). Down from twenty cigars a day to six and ready to stop. Combination nicotine replacement added to varenicline from the quit date improves the chance of success; cigars count like any other tobacco, so no cigar is safe to keep. **S**
   - Quit date one week from today.
   - From the quit date: nicotine 21 mg patch each morning and 4 mg lozenges as needed, up to 10 a day; lozenge rather than gum because gum sticks to the obturator.
   - Continue varenicline 1 mg twice daily.
   - Quitline calls weekly around the quit date; a written plan for the hours after meals and work, when he used to smoke.
2. **Hypernasal speech and nasal leakage** (R49.21). Better with the reline; the new obturator should seal fully. **S**
   - Speech-language therapy rebooked within two weeks.
3. **Chronic pain at the maxillectomy site** (G89.29). Pain 4 of 10 now that the flange no longer presses. **S**
   - Continue acetaminophen 1,000 mg three times daily and saline rinses.
4. **Weight loss** (R63.4). Weight up 0.5 kg with easier eating and supplements. **S**
   - Continue the soft high-protein diet and supplements.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Tobacco use (cigars a day), readiness and quit date | Every visit | Completed today | About six cigars a day; quit date in one week |
| Medication safety | Varenicline adherence and side effects (nausea, sleep, dreams, mood) | Every visit; at least 12 weeks, extended to 24 weeks or more | Completed today | No nausea after food; milder dreams; mood steady |
| Medication safety | Combination nicotine replacement (patch and lozenge) | From the quit date for at least 8 to 12 weeks | Ordered | 21 mg patch and 4 mg lozenge from the quit date |
| Self-management | Behavioral support (quitline and clinic sessions) | Weekly calls around the quit date, then every two to four weeks | Completed today | Three quitline calls since enrollment; weekly calls around the quit date |
| Examination | Head and neck surveillance examination (mouth, defect and neck) | Yearly by his head and neck surgeon more than five years after treatment; mouth checked at each visit | Completed today | Ulcer healed; no mass, induration or white or red patch; neck clear; yearly surgeon's examination booked for next month |
| Imaging | Head and neck imaging | Only for symptoms or signs more than five years after treatment | Not indicated | No symptoms or signs of recurrence |
| Examination | Second primary cancer counseling and symptom review | Every visit | Completed today | No hoarseness, trouble swallowing, cough with blood or blood in the urine; second primary risk explained again |
| Examination | Obturator fit, seal and hygiene | Every visit | Completed today | Relined obturator seals better; impressions for the new obturator taken last week |
| Referral | Speech and swallowing (hypernasality, nasal leakage) | Every visit; speech-language therapy as needed | Deferred | Speech-language therapy has not started: the first appointment was cancelled by the clinic and not rebooked. No harm so far: speech is clearer with the reline. Corrective action: rebooked within two weeks, with a reminder call |
| Self-management | Dental care (high-fluoride toothpaste, cleaning every three months) | Daily toothpaste; cleaning every three months | Completed today | Using high-fluoride toothpaste nightly; the two root caries found at the consultation were filled by his dentist |
| Examination | Weight and nutrition | Every visit | Completed today | 58.9 kg, up 0.5 kg |
| Survey | Pain score and function | Every visit | Completed today | 4 of 10 |
| Medication safety | Acetaminophen daily dose (no more than 3,000 mg) | Every visit | Completed today | 3,000 mg a day |
| Medication safety | Opioids | Avoid long-term opioids | Not indicated | Not needed |

## Goal progress

- Stop smoking cigars completely, at a pace he chooses, using varenicline and nicotine replacement. In progress; target 2026-10-26. **S**
- An obturator that seals and does not rub, so that speech is clear and liquids do not leak into his nose. In progress; target 2026-08-24. **S**
- Pain at 3 of 10 or less without opioids. In progress; target 2026-10-26. **S**
- Regain weight to at least 60 kg with a normal albumin. In progress; target 2026-10-26. **S**

## Guideline basis

- Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020), American Thoracic Society (Am J Respir Crit Care Med 2020;202(2):e5-e31)
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026), National Comprehensive Cancer Network
- American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016), American Cancer Society (CA Cancer J Clin 2016;66(3):203-239)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)

## Follow-up

- Quit date in one week, with quitline calls. Speech-language therapy within two weeks. Head and neck surgeon's yearly examination next month. Twelve-week review in six weeks, when the new obturator is fitted. **S**
- Next scheduled visit 2026-08-24: twelve-week review: five weeks without smoking, the new obturator and survivorship surveillance. **S**
